U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07693374) titled 'Chinese Medicinal Component Relieves CIPN and Mitochondria Function' on July 03.
Brief Summary: A randomized controlled trial was designed and conducted to confirm whether oral administration of the herb Moutan Cortex, which contains paeonol, can alleviate peripheral neuropathy in paclitaxel-treated cancer patients. This research project will validate our new preliminary findings demonstrating the neuroprotective effects after paclitaxel treatment. Importantly, our data are expected to elucidate the way Moutan Cortex induces neuroprotection in the clinical setting and provide a scientific basis for the development of new approaches ...